CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 1 of 1
Non-Antibody Products
Page 1,063 of 1,297
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Rivastigmine-d6 (tartrate) | An internal standard for the quantification of rivastigmine by GC- or LC-MS | 500 µg | 25633-500 | More Info |
| Rivastigmine (tartrate) | A ChE inhibitor that inhibits BChE and AChE (IC50s = 0.037 and 4.15 µ… | 1 g | 14270-1 | More Info |
| Rivastigmine (tartrate) | A ChE inhibitor that inhibits BChE and AChE (IC50s = 0.037 and 4.15 µ… | 100 mg | 14270-100 | More Info |
| Rivastigmine (tartrate) | A ChE inhibitor that inhibits BChE and AChE (IC50s = 0.037 and 4.15 µ… | 250 mg | 14270-250 | More Info |
| Rivastigmine (tartrate) | A ChE inhibitor that inhibits BChE and AChE (IC50s = 0.037 and 4.15 µ… | 500 mg | 14270-500 | More Info |
| Rivenprost | An EP4 receptor agonist (Kis = 0.7, 56, 620, and >10,000 nM, respectively,… | 1 mg | 13618-1 | More Info |
| Rivenprost | An EP4 receptor agonist (Kis = 0.7, 56, 620, and >10,000 nM, respectively,… | 100 µg | 13618-100 | More Info |
| Rivenprost | An EP4 receptor agonist (Kis = 0.7, 56, 620, and >10,000 nM, respectively,… | 500 µg | 13618-500 | More Info |
| Rizatriptan (benzoate salt) | A 5-HT1B and 5-HT1D receptor agonist (Kis = 4.3 and 10.1 nM, respectively)… | 10 mg | 16475-10 | More Info |
| Rizatriptan (benzoate salt) | A 5-HT1B and 5-HT1D receptor agonist (Kis = 4.3 and 10.1 nM, respectively)… | 25 mg | 16475-25 | More Info |
| Rizatriptan (benzoate salt) | A 5-HT1B and 5-HT1D receptor agonist (Kis = 4.3 and 10.1 nM, respectively)… | 5 mg | 16475-5 | More Info |
| Rizatriptan (benzoate salt) | A 5-HT1B and 5-HT1D receptor agonist (Kis = 4.3 and 10.1 nM, respectively)… | 50 mg | 16475-50 | More Info |
| Rizatriptan-d6 (benzoate salt) | An internal standard for the quantification of rizatriptan by GC- or LC-MS | 1 mg | 33369-1 | More Info |
| Rizatriptan-d6 (benzoate salt) | An internal standard for the quantification of rizatriptan by GC- or LC-MS | 5 mg | 33369-5 | More Info |
| Rizatriptan N-oxide | A potential impurity found in commercial preparations of rizatriptan; a de… | 1 mg | 35104-1 | More Info |
| Rizatriptan N-oxide | A potential impurity found in commercial preparations of rizatriptan; a de… | 10 mg | 35104-10 | More Info |
| Rizatriptan N-oxide | A potential impurity found in commercial preparations of rizatriptan; a de… | 5 mg | 35104-5 | More Info |
| RIZ1 (human recombinant) | Source: Recombinant N-terminal GST-tagged protein expressed in E. coli &bu… | 250 µg | 10765-250 | More Info |
| RJR 2429 (hydrochloride) | An agonist of nicotinic AChRs; selective for α4β2 or α7 s… | 10 mg | 29745-10 | More Info |
| RJR 2429 (hydrochloride) | An agonist of nicotinic AChRs; selective for α4β2 or α7 s… | 25 mg | 29745-25 | More Info |
| RJR 2429 (hydrochloride) | An agonist of nicotinic AChRs; selective for α4β2 or α7 s… | 5 mg | 29745-5 | More Info |
| (R)-(-)-JWH 073 N-(3-hydroxybutyl) metabolite | A purified single enantiomer of a major metabolite of JWH 073, produced by… | 1 mg | 10899-1 | More Info |
| (R)-(-)-JWH 073 N-(3-hydroxybutyl) metabolite | A purified single enantiomer of a major metabolite of JWH 073, produced by… | 10 mg | 10899-10 | More Info |
| (R)-(-)-JWH 073 N-(3-hydroxybutyl) metabolite | A purified single enantiomer of a major metabolite of JWH 073, produced by… | 5 mg | 10899-5 | More Info |
| RK-20448 | A multi-kinase inhibitor; inhibits Lck, Src, KDR / VEGF2R, and Tie-2 (IC50… | 1 mg | 25606-1 | More Info |
| RK-20448 | A multi-kinase inhibitor; inhibits Lck, Src, KDR / VEGF2R, and Tie-2 (IC50… | 10 mg | 25606-10 | More Info |
| RK-20448 | A multi-kinase inhibitor; inhibits Lck, Src, KDR / VEGF2R, and Tie-2 (IC50… | 5 mg | 25606-5 | More Info |
| RK-20448 | A multi-kinase inhibitor; inhibits Lck, Src, KDR / VEGF2R, and Tie-2 (IC50… | 500 µg | 25606-500 | More Info |
| RK-287107 | A TNKS1 and TNKS2 inhibitor (IC50s = 0.014 and 0.010 µM, respectivel… | 1 mg | 30998-1 | More Info |
| RK-287107 | A TNKS1 and TNKS2 inhibitor (IC50s = 0.014 and 0.010 µM, respectivel… | 10 mg | 30998-10 | More Info |
| RK-287107 | A TNKS1 and TNKS2 inhibitor (IC50s = 0.014 and 0.010 µM, respectivel… | 5 mg | 30998-5 | More Info |
| RK-682 (calcium salt) | An inhibitor of the PTPs that blocks phosphorylation of CD45 and VHR (IC50… | 2.5 mg | 19450-25 | More Info |
| RK-682 (calcium salt) | An inhibitor of the PTPs that blocks phosphorylation of CD45 and VHR (IC50… | 500 µg | 19450-500 | More Info |
| (R)-Ketamine (hydrochloride) | An analytical reference standard categorized as an arylcyclohexylamine; is… | 100 mg | 38398-100 | More Info |
| (R)-Ketamine (hydrochloride) | An analytical reference standard categorized as an arylcyclohexylamine; is… | 50 mg | 38398-50 | More Info |
| RKI-1313 | An inhibitor of ROCK1 and 2 (IC50s = 34 and 8 µM, respectively); has… | 1 mg | 22933-1 | More Info |
| RKI-1313 | An inhibitor of ROCK1 and 2 (IC50s = 34 and 8 µM, respectively); has… | 10 mg | 22933-10 | More Info |
| RKI-1313 | An inhibitor of ROCK1 and 2 (IC50s = 34 and 8 µM, respectively); has… | 5 mg | 22933-5 | More Info |
| RKI-1447 | A ROCK1 and 2 inhibitor (IC50s = 14.5 and 6.2 nM, respectively) that funct… | 10 mg | 16278-10 | More Info |
| RKI-1447 | A ROCK1 and 2 inhibitor (IC50s = 14.5 and 6.2 nM, respectively) that funct… | 5 mg | 16278-5 | More Info |
| RKI-1447 | A ROCK1 and 2 inhibitor (IC50s = 14.5 and 6.2 nM, respectively) that funct… | 50 mg | 16278-50 | More Info |
| (R)-KT109 | An inhibitor of DAGLβ, DAGLα, and ABHD6 (IC50s = 0.79, 25.12, a… | 1 mg | 25682-1 | More Info |
| (R)-KT109 | An inhibitor of DAGLβ, DAGLα, and ABHD6 (IC50s = 0.79, 25.12, a… | 500 µg | 25682-500 | More Info |
| (R)-Lansoprazole | A pure enantiomer of lansoprazole that inhibits acid formation in isolated… | 10 mg | 18235-10 | More Info |
| (R)-Lansoprazole | A pure enantiomer of lansoprazole that inhibits acid formation in isolated… | 100 mg | 18235-100 | More Info |
| (R)-Lansoprazole | A pure enantiomer of lansoprazole that inhibits acid formation in isolated… | 50 mg | 18235-50 | More Info |
| (R)-(-)-Linoleyl-2'-Hydroxy-1'-Propylamide | A homolog of LOEA, characterized by the addition of an (R)-α-methyl… | 1 mg | 9001234-1 | More Info |
| (R)-(-)-Linoleyl-2'-Hydroxy-1'-Propylamide | A homolog of LOEA, characterized by the addition of an (R)-α-methyl… | 10 mg | 9001234-10 | More Info |
| (R)-(-)-Linoleyl-2'-Hydroxy-1'-Propylamide | A homolog of LOEA, characterized by the addition of an (R)-α-methyl… | 5 mg | 9001234-5 | More Info |
| (R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide | A homolog of LOEA, characterized by the addition of an (R)-α-methyl… | 1 mg | 9001233-1 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile